major surpris outlook bracket
larg track expect slightli higher rev off-set
lower gm teladoc report rev mln mln
cons/cs y/i rev came within tdoc outlook
rang mln tdoc organ revenue growth vs
adjust ebitda mln essenti line
cons/cs mln gross margin ratio declin
bp y/i bp cons/cs manag
character gm trend line intern expect
strong visit trend pmpm impact busi mix total
visit mln increas y/i y/i organ
annual util rate slightli ahead y/i pmpm
compar year ago pro-forma advanc
medic pmpm declin result member mix
impact new health plan member
maintain revenu ebidta ep outlook
expect revenu mln mln adjust
ebitda mln mln expect behavior health
total revenu growth exceed
comment topic note ncqa two-week
extens part process compani expect
reaccredit contract note reach
agreement expand much larger popul howev compani
provid specif outlook contract financi impact given
roll-out plan publicli disclos final respect
pend aet contract renew say feel good
concern
valuat metric
number share
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
largest telemedicin compani world
public virtual health provid compani use
combin web mobil app video phone platform
connect patient physician time demand
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
valuat assum
maintain current one-year forward ev/revenu multipl
roughli month would primarili driven
faster expect increas tdoc penetr
provider-driven telehealth market signific client win higher
expect util rate
grey valuat assum
trade ev/revenu multipl revenu
estim event loss major contract failur
improv margin gener increment revenu current
 close
compani mention price
